• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ADMEDUS REGEN PTY LTD CARDIOCEL NEO; INTRACARDIAC PATCH OR PLEDGET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ADMEDUS REGEN PTY LTD CARDIOCEL NEO; INTRACARDIAC PATCH OR PLEDGET Back to Search Results
Model Number EC0404N
Device Problems Insufficient Information (3190); Appropriate Term/Code Not Available (3191)
Patient Problem Stenosis (2263)
Event Date 06/01/2023
Event Type  Injury  
Manufacturer Narrative
Initial report, device not returned for inspection.Review of batch record did not identify any deviations or errors.
 
Event Description
This is an initial report.The following report was provided to anteris through the distributor lemaitre vascular on 07/20/2023.This incident occurred at a hospital in (b)(6).Per the physician's narrative, the patch was implanted on (b)(6) 2022 as a transannular patch in a fallot patient with pulmonary atresia and previous palliation with ductal stent.The native pa was diminutive and the reconstruction was in great part at expense of the patch (the new pa was in great part made from cardiocel).The patient developed estenosis of left pulmonary artery, treated in an occasion by cath lab procedure.In a second occasion the interventionism failed.The patient was presented for redo surgery, and in the or ((b)(6) 2023) we observed a huge reaction to the patch, which was narrowing the pulmonary artery.There was a thick neointima, easily separating from the original patch.It was sent to histology.Histology: fibroconnective tissue, with histiocitic cellularity, fibrin and inflammatory infiltration, and reactive fibroblasts.
 
Manufacturer Narrative
Review of manufacturing record for the lot in question did not show any deviations to the manufacturing process or errors.There were no manufacturing changes during this time period to suggest a change on the product.No additional information was provided by the initial reporter.While anteris continues to monitor, it appears at this time the event to be unlikely related to the product but rather associated with the complex intervention and challenges of vascular reconstruction in tetralogy of fallot patients.Stenosis of repair causing obstruction of flow through repaired vessel is listed as a potential hazard.The potential cause is intimal hyperplasia caused by vessel injury during reconstruction or repair.Flow obstruction is also listed as a potential adverse event in the product ifu.
 
Event Description
This is an final report.The following report was provided to anteris through the distributor lemaitre vascular on 07/20/2023.This incident occurred at a hospital in madrid, spain.Per the physician's narrative, "the patch was implanted on (b)(6) 2022 as a transannular patch in a fallot patient with pulmonary atresia and previous palliation with ductal stent.The native pa was diminutive and the reconstruction was in great part at expense of the patch (the new pa was in great part made from cardiocel).The patient developed estenosis of left pulmonary artery, treated in an occasion by cath lab procedure.In a second occasion the interventionism failed.The patient was presented for redo surgery, and in the operating room ((b)(6) 2023) we observed a huge reaction to the patch, which was narrowing the pulmonary artery.There was a thick neointima, easily separating from the original patch.It was sent to histology.Histology: fibroconnective tissue, with histiocitic cellularity, fibrin and inflammatory infiltration, and reactive fibroblasts.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARDIOCEL NEO
Type of Device
INTRACARDIAC PATCH OR PLEDGET
Manufacturer (Section D)
ADMEDUS REGEN PTY LTD
26 harris road
malaga, western australia 6080
AS  6080
Manufacturer (Section G)
ADMEDUS REGEN PTY LTD
26 harris road
malaga, western australia 6080
AS   6080
Manufacturer Contact
jim chapman
806 blue gentien road
suite 340
eagan, MN 55121
6514930606
MDR Report Key17494856
MDR Text Key320765990
Report Number3012664855-2023-00001
Device Sequence Number1
Product Code DXZ
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
K130872
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/09/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/01/2023
Device Model NumberEC0404N
Device Lot NumberM20035-0191
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/01/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention; Hospitalization;
Patient Age3 MO
Patient SexPrefer Not To Disclose
Patient EthnicityHispanic
-
-